The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APOLLO ENDOSURGERY INC | COM | 03767D108 | 61,650,522 | 6,183,603 | SH | SOLE | 6,183,603 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 5,177,634 | 8,218,467 | SH | SOLE | 8,218,467 | 0 | 0 | ||
PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 221,361,135 | 5,328,867 | SH | SOLE | 5,328,867 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 110,053,269 | 2,896,901 | SH | SOLE | 2,896,901 | 0 | 0 |